A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Archives of General Psychiatry

• Publication date

  1993-05-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1001/ARCHPSYC.1993.01820170065008PMID 8489327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Controlled Comparison of Adjuvant Lithium Carbonate or Thyroid Hormone in Clomipramine‐Treated Patients with Obsessive‐Compulsive Disorder

  1991cited by this paper
• Augmentation regimens for depression.

  1991cited by this paper
• Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.

  1991cited by this paper
• Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings.

  1991cited by this paper
• Lithium Augmentation in Antidepressant-Resistant Patients a Quantitative Analysis

  1991cited by this paper
• Data analysis for research designs

  1990cited by this paper
• A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants.

  1990cited by this paper
• Treatment of imipramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine.

  1989cited by this paper
• A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders

  1989cited by this paper
• Treatment of Depressions Resistant to Tricyclic Antidepressants, Related Drugs or MAO-Inhibitors by Lithium Addition: Review of the Literature

  1989cited by this paper
• Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.

  1989cited by this paper
• What is the duration for augmentation with T3 or lithium in resistant depression?

  1989cited by this paper
• T3 and lithium potentiation of tricyclic antidepressants.

  1988cited by this paper
• Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study.

  1988cited by this paper
• T3 and lithium potentiation of tricyclic antidepressants.

  1988cited by this paper
• The power of analysis: statistical perspectives. Part 2.

  1988cited by this paper
• Failure of T3 to potentiate tricyclic antidepressant response.

  1987cited by this paper
• Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.

  1986cited by this paper
• Variability of response to lithium augmentation in refractory depression.

  1986cited by this paper
• The Benefit of Lithium Carbonate Adjunct in Refractory Depression — Fact or Fiction? *

  1986cited by this paper
• Lithium potentiation of antidepressant treatment.

  1984cited by this paper
• Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine.

  1984cited by this paper
• Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.

  1983cited by this paper
• Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

  1983cited by this paper
• Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

  1982cited by this paper
• Lithium Induces Rapid Relief of Depression in Tricyclic Antidepressant Drug Non-Responders

  1981cited by this paper
• Combined Therapy of T3 and Antidepressants in Depression

  1979cited by this paper
• Effects of triiodothyronine on drug levels and cardiac function in depressed patients treated with imipramine.

  1979cited by this paper
• Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women

  1977cited by this paper
• [The use of triiodothyronine in the treatment of depression].

  1975cited by this paper
• Combined Thyroid (Triiodothyronine)‐Tricyclic Antidepressant Treatment in Depressive States

  1974cited by this paper
• Thyroid hormone and tricyclic antidepressants in resistant depressions.

  1970cited by this paper
• Diagnosis and Drug Treatment of Psychiatric Disorders

  1969cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Quantitative evaluation of multiple treatment regimens for treatment-resistant depression

  2025cites this paper
• The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members

  2025cites this paper
• A systematic review of augmentation strategies for patients with major depressive disorder.

  2025cites this paper
• Rethinking the medication management of major depression

  2023cites this paper
• Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis.

  2023cites this paper
• Augmentation Strategies For Treatment Resistant Major Depression: A Systematic Review And Network Meta-Analysis.

  2022cites this paper
• Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review

  2021cites this paper
• Role of central serotonin and noradrenaline interactions in the antidepressants' action: Electrophysiological and neurochemical evidence.

  2021cites this paper
• Thyroid hormone treatment in the management of treatment‐resistant unipolar depression: a systematic review and meta‐analysis

  2020influential citation
• Pharmacological Treatments for Patients with Treatment-Resistant Depression

  2020cites this paper
• Inadequate Response to Antidepressant Treatment in Major Depressive Disorder.

  2020cites this paper
• The Pharmacotherapy of Impulsive Aggression in Psychopathic Disorders

  2020cites this paper
• The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: A systematic review and meta-analysis.

  2020cites this paper
• Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines

  2020influential citation
• Chronische Depression – Klassifikation und therapeutische Maßnahmen

  2020cites this paper
• Treatment-resistant depression - recommendations of the National Consultant in the field of psychiatry.

  2019cites this paper
• Effect of lithium on suicide and mortality in mood disorders: A systematic review

  2019cites this paper
• Lithium treatment for unipolar major depressive disorder: Systematic review

  2019cites this paper
• Guía de práctica clínica sobre el manejo de la depresión mayor en el adulto

  2018cites this paper
• Liothyronine for Depression: A Review and Guidance for Safety Monitoring.

  2017cites this paper
• Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults

  2017cites this paper
• 4.07 – Hypothalamic–Pituitary–Thyroid Axis

  2017cites this paper
• Liothyronine for Depression: A Review and Guidance for Safety Monitoring.

  2017cites this paper
• Treatment of Depression with Lithium

  2016cites this paper
• [Potentiation strategies].

  2016cites this paper
• Behandlung depressiver Störungen

  2016cites this paper
• Depression Screening, Diagnosis, and Treatment Across the Lifespan.

  2016cites this paper
• DRAFT Health Care Guideline Depression in Primary Care

  2016cites this paper
• Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.

  2015cites this paper
• Bipolar (Manic Depressive) Disorders

  2015cites this paper
• Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder

  2015cites this paper
• Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability.

  2015cites this paper
• Thyroid Function and Depression

  2014cites this paper
• PPT Polypharmazie in der Behandlung depressiver Störungen

  2014cites this paper
• How treatable is refractory depression?

  2014cites this paper
• A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.

  2014influential citation
• California State Hospital Violence Assessment and Treatment (Cal-VAT) guideline.

  2014cites this paper
• California State Hospital Violence Assessment and Treatment (Cal-VAT) guidelines

  2014cites this paper
• Role of Lithium Augmentation in the Management of Major Depressive Disorder

  2014cites this paper
• Antidepressant-Antianxiety Agents

  2013cites this paper
• Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression

  2013cites this paper
• An expert panel review of clinical challenges in psychiatry RECENT FINDINGS AND CURRENT STATUS OF AUGMENTATION STRATEGIES

  2013cites this paper
• Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey: A Microsimulation Approach.

  2013cites this paper
• Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

  2013cites this paper
• Kapitel 11 – Chronische und therapieresistente Depressionen (ICD-10 F3)

  2013cites this paper
• Evidence-Based Korean Pharmacological Treatment Guideline for Depression, Revised Edition (III) : Dose Increment, Switching, Combination, and Augmentation Strategy in Antidepressant Therapy

  2013cites this paper
• Pharmacological interventions for treatment-resistant depression in adults.

  2013cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

  2013influential citation
• Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

  2013influential citation
• Chemotherapy in psychiatry

  2013cites this paper
• How does liothyronine prevent ECT-induced memory impairment?

  2013cites this paper
• Neuropsychiatric manifestations of thyroid disease.

  2013cites this paper
• Treatment-resistant depression: therapeutic trends, challenges, and future directions

  2012cites this paper
• Treating major depressive disorder to remission. Looking for a complete remission

  2012cites this paper
• Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?

  2012cites this paper
• Prefazione – La caratterizzazione clinica delle sindromi depressive: riferimenti storici e sviluppi futuri

  2012cites this paper
• Combination Pharmacotherapy for Psychiatric Disorders in Children and Adolescents

  2012cites this paper
• Managing the Patient with Co-Morbid Depression and an Anxiety Disorder

  2012cites this paper
• General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry

  2011influential citation
• Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients

  2011cites this paper
• augmentation of antidepressants in tricyclic non-responders Predictors of response to lithium and triiodothyronine

  2011cites this paper
• Hormone treatment of depression

  2011cites this paper
• T3 augmentation in major depressive disorder: safety considerations.

  2011cites this paper
• Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

  2010cites this paper
• 125I-labelled iodothyronines: useful tools for studies of effects of an antidepressant drug fluoxetine in the rat

  2010cites this paper
• Therapeutic Options for Treatment-Resistant Depression

  2010cites this paper
• The tricyclic antidepressant desipramine inhibits T3 import into primary neurons.

  2010cites this paper
• How best to manage treatment-resistant depression?

  2010cites this paper
• Therapeutic Armamentarium for Treating Depression

  2010cites this paper
• Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants

  2010cites this paper
• Switching, combination, and augmentation strategies for major depressive disorder.

  2010cites this paper
• Use of endocrine hormones for treating depression.

  2010cites this paper
• Long-Term Outcome after Lithium Augmentation in Unipolar Depression: Focus on HPA System Activity

  2009cites this paper
• Is a Medical Illness Causing Your Patient's Depression? Endocrine, Neurologic, Infectious, or Malignant Processes Could Cause Mood Symptoms

  2009cites this paper
• Polypharmazie in der Behandlung depressiver Störungen

  2009cites this paper
• Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder.

  2009cites this paper
• Treatment Options for the Patient Who Does Not Respond Well to Initial Antidepressant Therapy

  2009cites this paper
• Combining Medications to Achieve Remission

  2009cites this paper
• Clinical practice recommendations for depression

  2009cites this paper
• The Thyroid Patient Advocacy-UK (TPA-UK) Response to: "A Statement from the British Thyroid Association Executive Committee on Armour® Thyroid"

  2008cites this paper
• Augmentation with olanzapine in TCA‐refractory depression with melancholic features: a consecutive case series

  2008cites this paper
• Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.

  2008cites this paper
• Biologische behandlung unipolarer depressiver störungen in der allgemeinärztlichen versorgung: Leitlinien der World Federation of Societies of Biological Psychiatry (WFSBP)

  2008cites this paper
• Neuroendocrine functions, mood and quality of life

  2007cites this paper
• [Twenty-five years of lithium augmentation].

  2007cites this paper
• Combined treatments for major depression

  2007cites this paper
• STAR*D: what have we learned?

  2007cites this paper
• [Modern antidepressant treatment].

  2007cites this paper
• Treatment-resistant depression: review of pharmacologic antidepressant strategies

  2007influential citation
• Interpersonal psychotherapy and mirtazapine versus mirtazapine alone in treatment resistant depressed patients with sequential functional brain scans of dopamine D2 receptors with IBZM spect

  2007cites this paper
• Receptores 5HT2 y lugares de unión DE 3H-imipramina Y 3H-paroxetina en membrana de plaqueta en trastorno bipolar.

  2007cites this paper
• Fünfundzwanzig Jahre Lithiumaugmentation

  2007cites this paper
• Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation

  2007cites this paper
• Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

  2007cites this paper
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

  2007influential citation
• CHAPTER 17 – Depression

  2007cites this paper
• Augmentation strategies for treatment‐resistant depression: a literature review

  2007cites this paper
• Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.

  2007cites this paper
• Comparing the Efficacy of add-on Nortryptiline With Triiodothyronine in the Management of Citalopram-Resistant Depression

  2007cites this paper
• [Augmentation strategies for therapy resistant depression - a review].

  2007cites this paper